Kun He
- Biotechnology top 2%
- Pharmacology top 5%
- Pharmacology top 5%
- Molecular Biology
- Complementary and alternative medicine top 10%
- Topics
- Pharmacogenetics and Drug Metabolism (2 papers)Ferroptosis and cancer prognosis (2 papers)Microbial Metabolism and Applications (2 papers)
- Cited by
- BiotechnologyPharmacology
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Kun He
12 papers receiving 379 citations
Peers
Comparison fields: 5 of 58
- Biotechnology 242
- Pharmacology 175
- Pharmacology 116
- Molecular Biology 110
- Complementary and alternative medicine 40
Countries citing papers authored by Kun He
This map shows the geographic impact of Kun He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun He more than expected).
Fields of papers citing papers by Kun He
This network shows the impact of papers produced by Kun He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun He. The network helps show where Kun He may publish in the future.
Co-authorship network of co-authors of Kun He
This figure shows the co-authorship network connecting the top 25 collaborators of Kun He. A scholar is included among the top collaborators of Kun He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun He. Kun He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 28 | |
| 2 | 3 | |
| 3 | 12 | |
| 4 | 3 | |
| 5 | 21 | |
| 6 | 19 | |
| 7 | 5 | |
| 8 | 245 | |
| 9 | 2 | |
| 10 | 2 | |
| 11 | 41 | |
| 12 | [Nano-ESI-MS/MS identification on apoptosis qssociated proteins induced by inhibiting ubiquitin-proteasome pathway]. | 2 |
About Kun He
Kun He is a scholar working on Biotechnology, Pharmacology and Hematology, having authored 12 papers that have together received 383 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (2 papers), Ferroptosis and cancer prognosis (2 papers) and Microbial Metabolism and Applications (2 papers). The work is most often cited by research in Biotechnology (242 citations), Pharmacology (116 citations) and Pharmacology (175 citations). Kun He has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Wanping Chen, Youxiang Zhou, Yuanyuan Lu, Xiaoli Ding, Fusheng Chen, Yi He, Xiaoxiao Guo, Runfa Chen, Yanchun Shao and István Molnár. Their work appears in journals such as Clinical Cancer Research, Chemical Engineering Science and Chemical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.